• Certara Announces First Recipients of Certara-Monash University Industry Drug Development Fellowships

    Jun 25, 2019, 09:46 by Michael Croft
    PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
    Full story
  • Right-Sizing Site Selection: Predicting Enrollment

    Jun 25, 2019, 08:20 by Michael Croft

    Clinical Research News | Janssen is one of a growing number of life science companies actively building its data science capabilities to improve clinical trial operations. The centerpiece of these efforts is a feasibility intelligence platform that uses real-world evidence (RWE) and data analytics to inform site selection strategies for studies.

    Full story
  • ERT Participates in Groundbreaking, Digital Technology Research

    Jun 24, 2019, 08:35 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jun 24, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its involvement in a groundbreaking project to enhance drug development and improve the clinical management of mobility loss
    Full story
  • Right-Sizing Site Selection: Does Data Hold Answers?

    Jun 24, 2019, 08:30 by Michael Croft

    Clinical Research News | Study sponsors are experimenting with strategies to improve the site selection process, leaning more heavily than ever before on evidence and machine learning techniques, and each other, to solve the problem child of clinical research—the low or no enrollers. So far, there are no clear winners.

    Full story
  • ERT Showcases Scientific and Technological Expertise in Improving Clinical Research at DIA Annual Meeting

    Jun 20, 2019, 10:29 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jun 20, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its scientific and technological experts will present a series of innovative and educational live sessions and posters at the 2019 Drug Information Association (DIA) Annual Meeting in San Diego, June 23-27
    Full story
  • Adjusting To GDPR, One Year Later

    Jun 20, 2019, 10:05 by Michael Croft

    Clinical Research News | A year out from the regulation's launch, Mariya Pinskaya, Principal Consultant at Areva Consulting, sees a very consistent experience for trial participants, even if study teams are working harder in the background.

    Full story
  • IDDI IN COLLABORATION WITH ROCHE HAVE IDENTIFIED WHY USING DISEASE FREE SURVIVAL AS A PRIMARY ENDPOINT IN EARLY BREAST CANCER IS THE WAY FORWARD

    Jun 20, 2019, 09:48 by Michael Croft
    LOUVAIN-LA-NEUVE, BELGIUM - Jun 20, 2019 - IDDI’s findings suggest that it is appropriate to use disease-free survival (DFS) as a surrogate for overall survival (OS) in trials in HER-2-positive, early breast cancer
    Full story
  • Shimmer and ClearSky Announce Partnership to Improve Analysis of Wearable Sensor Data for CNS Diseases

    Jun 19, 2019, 08:14 by Michael Croft
    CAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
    Full story
  • Signant Health Experts Share Benefit of Integrating Patient-Centric Technology Solutions at Global Life Sciences Annual Forum DIA 2019

    Jun 18, 2019, 12:45 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jun 18, 2019 - Signant Health (formerly CRF Health and Bracket) will provide expert insights at the forthcoming DIA Global Annual Meeting in San Diego, CA
    Full story
  • Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

    Jun 18, 2019, 09:52 by Michael Croft
    WAYNE, PA - Jun 18, 2019 - Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health, today announced  its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to enhance overall data quality oversight and ensure regulatory compliance within clinical trials
    Full story
  • SCOPE Europe Returns To Spain

    Jun 18, 2019, 07:55 by Michael Croft

    Clinical Research News | SCOPE, the Summit for Clinical Ops Executives, is heading back to Barcelona for a deep dive into the challenges and opportunities for clinical research in Europe and beyond.

    Full story
  • TrialAssure's New Web Portal Shares Trial Results In Plain Language

    Jun 17, 2019, 06:30 by Michael Croft

    Clinical Research News | TrialAssure recently launched TrialResults.com, a web portal for clinical trial sponsors to publicly share plain language, or lay, summaries with clinical trial participants.

    Full story
  • Rho Facilitates Conversation on Change and Collaboration at DIA 2019

    Jun 13, 2019, 19:42 by Michael Croft
    DURHAM, NC - Jun 14, 2019 - Rho Facilitates Conversation on Change and Collaboration at DIA 2019Experts fromCRO to share best practices and lessons learned on Change Management andEffective Stakeholder Collaboration   WHAT:                 Rho, a full-service contract research organization (CRO), will highlight its clinical trial expertise during the Drug Information Association (DIA) Annual Meeting, being held June 23-27 in San Francisco
    Full story
  • Signant Health Appoints Lawrence Miller as Chief Technology Officer

    Jun 13, 2019, 09:12 by Michael Croft
    PLYMOUTH MEETING, PA - Jun 13, 2019 - Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer.  Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services
    Full story
  • Dassault Systèmes Acquires Medidata Solutions For $5.8 Billion

    Jun 12, 2019, 12:35 by Michael Croft

    Clinical Research News | Dassault Systèmes announced this morning that it is acquiring Medidata Solutions at a price of $92.25 per share, representing an enterprise value of $5.8 billion.

    Full story
  • Certara’s Simcyp PBPK Modeling and Simulation Technology Achieves First FDA Virtual Bioequivalence Approval for ‘Complex’ Generic Drug

    Jun 12, 2019, 08:21 by Michael Croft
    PRINCETON, NJ - Jun 12, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its Simcyp® physiologically-based pharmacokinetic (PBPK) modeling and simulation technology was used to demonstrate bioequivalence (BE) for the US Food and Drug Administration (FDA) approval of a complex generic drug on the agency’s abbreviated new drug application (ANDA) pathway
    Full story
  • Amsterdam University Medical Center wins MR Solutions’ newly launched Image of the Year Award

    Jun 11, 2019, 12:53 by Michael Croft
    GUILDFORD, UNITED KINGDOM - Jun 11, 2019 - The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular research image
    Full story
  • ERT Enhances its Adaptive eC-SSRS for More Effective Suicide Risk Assessment

    Jun 11, 2019, 09:49 by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jun 11, 2019 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced advancements to its unique electronic Columbia-Suicide Severity Rating Scale (eC-SSRS), an electronic, self-rated patient reported outcome assessment conducted at investigative sites to assess treatment-emergent suicidal ideation and behavior (SIB) during clinical trials
    Full story
  • Greenphire Forms Strategic Partnership With Lazarex Cancer Foundation

    Jun 11, 2019, 08:00 by Michael Croft

    Clinical Research News Brief | Greenphire recently announced that it has formed a partnership with the Lazarex Cancer Foundation, which will implement Greenphire's ClinCard participant reimbursement technology to remove financial burdens for the oncology patients it supports across the United States.

    Full story
  • Quanticate Expands Presence in North America with New Toronto Office

    Jun 11, 2019, 03:56 by Michael Croft
    TORNTO, ON, CANADA - Jun 11, 2019 - Quanticate, a leading global data-focused clinical research organisation (CRO), has announced plans to expand its presence in North America with the opening of a new office in Toronto
    Full story
  • «
  • 191
  • 192
  • 193
  • 194 (current)
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • »